Aldeyra Therapeutics, Inc. (ALDX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: -$54.38M2013: -$40.22M2014: $6.28M2015: $24.88M2016: $21.65M2017: $39.60M2018: $86.62M2019: $48.08M2020: $59.51M2021: $205.74M2022: $151.01M2023: $119.80M2024: $71.00M2025: $44.25M$44.25M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$44.25M-37.7%
2024$71.00M-40.7%
2023$119.80M-20.7%
2022$151.01M-26.6%
2021$205.74M+245.7%
2020$59.51M+23.8%
2019$48.08M-44.5%
2018$86.62M+118.7%
2017$39.60M+82.9%
2016$21.65M-13.0%
2015$24.88M+295.9%
2014$6.28M+115.6%
2013-$40.22M+26.0%
2012-$54.38M